137 related articles for article (PubMed ID: 22161472)
21. Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.
Oura F; Yajima Y; Nakata M; Taniue K; Akiyama T; Nakada H; Yamamoto K; Fujita-Yamaguchi Y
Biosci Trends; 2015 Feb; 9(1):49-55. PubMed ID: 25787909
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen.
Takahashi HK; Metoki R; Hakomori S
Cancer Res; 1988 Aug; 48(15):4361-7. PubMed ID: 3390832
[TBL] [Abstract][Full Text] [Related]
23. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
Itzkowitz SH; Yuan M; Montgomery CK; Kjeldsen T; Takahashi HK; Bigbee WL; Kim YS
Cancer Res; 1989 Jan; 49(1):197-204. PubMed ID: 2908846
[TBL] [Abstract][Full Text] [Related]
24. Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.
Inoue M; Yamashina I; Nakada H
Biochem Biophys Res Commun; 1998 Apr; 245(1):23-7. PubMed ID: 9535776
[TBL] [Abstract][Full Text] [Related]
25. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and molecular recognition studies of the HNK-1 trisaccharide and related oligosaccharides. The specificity of monoclonal anti-HNK-1 antibodies as assessed by surface plasmon resonance and STD NMR.
Tsvetkov YE; Burg-Roderfeld M; Loers G; Ardá A; Sukhova EV; Khatuntseva EA; Grachev AA; Chizhov AO; Siebert HC; Schachner M; Jiménez-Barbero J; Nifantiev NE
J Am Chem Soc; 2012 Jan; 134(1):426-35. PubMed ID: 22087768
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
Mazal D; Lo-Man R; Bay S; Pritsch O; Dériaud E; Ganneau C; Medeiros A; Ubillos L; Obal G; Berois N; Bollati-Fogolin M; Leclerc C; Osinaga E
Cancer Immunol Immunother; 2013 Jun; 62(6):1107-22. PubMed ID: 23604173
[TBL] [Abstract][Full Text] [Related]
28. Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique.
Pope ME; Soste MV; Eyford BA; Anderson NL; Pearson TW
J Immunol Methods; 2009 Feb; 341(1-2):86-96. PubMed ID: 19041872
[TBL] [Abstract][Full Text] [Related]
29. Further characterization of the binding properties of two monoclonal antibodies recognizing human Tn red blood cells.
Wua AM; Wub JH; Kuoa HW; Herpa A
J Biomed Sci; 2005; 12(1):153-66. PubMed ID: 15864747
[TBL] [Abstract][Full Text] [Related]
30. A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance.
Debotton N; Zer H; Parnes M; Harush-Frenkel O; Kadouche J; Benita S
Eur J Pharm Biopharm; 2010 Feb; 74(2):148-56. PubMed ID: 19835957
[TBL] [Abstract][Full Text] [Related]
31. Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies.
Lung FD; Chen CH; Liou CC; Chen HY
J Pept Res; 2004 Apr; 63(4):365-70. PubMed ID: 15102054
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the specificity and thermodynamics of the interaction between low affinity antibodies and carbohydrate antigens using fluorescence spectroscopy.
Engström HA; Andersson PO; Ohlson S
J Immunol Methods; 2005 Feb; 297(1-2):203-11. PubMed ID: 15777943
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
34. Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody.
Yao Z; Sakahara H; Zhang M; Kobayashi H; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1995 Feb; 22(2):199-203. PubMed ID: 7767313
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the results obtained by ELISA and surface plasmon resonance for the determination of antibody affinity.
Heinrich L; Tissot N; Hartmann DJ; Cohen R
J Immunol Methods; 2010 Jan; 352(1-2):13-22. PubMed ID: 19854197
[TBL] [Abstract][Full Text] [Related]
36. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
[TBL] [Abstract][Full Text] [Related]
37. pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen.
Matsumoto Y; Zhang Q; Akita K; Nakada H; Hamamura K; Tokuda N; Tsuchida A; Matsubara T; Hori T; Okajima T; Furukawa K; Urano T; Furukawa K
Biochem Biophys Res Commun; 2012 Mar; 419(1):7-13. PubMed ID: 22306014
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen.
Huang J; Byrd JC; Siddiki B; Yuan M; Lau E; Kim YS
Dis Markers; 1992; 10(2):81-94. PubMed ID: 1281060
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
